These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8814995

  • 1. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.
    Mueller BM.
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():65-80. PubMed ID: 8814995
    [Abstract] [Full Text] [Related]

  • 2. Properties of metastasizing and nonmetastasizing human melanoma cells.
    van Muijen GN, Danen EH, de Vries TJ, Quax PH, Verheijen JH, Ruiter DJ.
    Recent Results Cancer Res; 1995; 139():105-22. PubMed ID: 7597284
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC, Quax PH, Löwik CW, Verheijen JH.
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor invasion, proteolysis, and angiogenesis.
    Thorgeirsson UP, Lindsay CK, Cottam DW, Gomez DE.
    J Neurooncol; 1994 Sep; 18(2):89-103. PubMed ID: 7525888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
    Baricos WH, Cortez SL, el-Dahr SS, Schnaper HW.
    Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
    [Abstract] [Full Text] [Related]

  • 13. Proteolytic enzymes in proliferation and neoplastic metastases formation.
    Gołaszewski Z, Gacko M, Chyczewska E, Chyczewski L, Myćko G, Worowski K.
    Rocz Akad Med Bialymst; 1997 Apr; 42 Suppl 1():48-59. PubMed ID: 9337523
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proteases and protease inhibitors in tumor progression.
    DeClerck YA, Imren S, Montgomery AM, Mueller BM, Reisfeld RA, Laug WE.
    Adv Exp Med Biol; 1997 Apr; 425():89-97. PubMed ID: 9433492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression].
    Ntayi C, Hornebeck W, Bernard P.
    Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935
    [Abstract] [Full Text] [Related]

  • 19. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 20. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.
    Hearing VJ, Law LW, Corti A, Appella E, Blasi F.
    Cancer Res; 1988 Mar 01; 48(5):1270-8. PubMed ID: 2963689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.